AGP
RVMD icon

Artia Global Partners’s Revolution Medicines RVMD Stock Holding History

Artia Global Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7M Buy
185,390
+60,400
+48% +$8.82M 6.41% 5
2026
Q1 		$12.2M Buy
124,990
+20,800
+20% +$2.1M 2.43% 10
2025
Q4 		$8.3M Hold
104,190
– – 1.18% 17
2025
Q3 		$4.87M Hold
104,190
– – 0.77% 20
2025
Q2 		$3.83M Hold
104,190
– – 0.92% 18
2025
Q1 		$3.68M Sell
104,190
-180,000
-63% -$7.31M 0.93% 19
2024
Q4 		$12.4M Buy
284,190
+188,305
+196% +$9.5M 4.44% 11
2024
Q3 		$4.35M Buy
+95,885
New +$4.18M 1.19% 15

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Artia Global Partners's RVMD Position: Q2 2026 in Review

Artia Global Partners increased its Revolution Medicines (RVMD) stake by 48% in Q2 2026, buying an estimated $8.82M and bringing the position to 185,390 shares worth $34.7M. The position accounts for 6.41% of the portfolio, ranked #5.

Artia Global Partners first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Artia Global Partners held 185,390 shares of Revolution Medicines worth $34.7M as of Q2 2026.
  • Artia Global Partners bought 60,400 Revolution Medicines shares in Q2 2026, an estimated $8.82M.
  • Revolution Medicines made up 6.41% of Artia Global Partners's portfolio in Q2 2026, its #5 holding.
  • Artia Global Partners first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.